Navigation Links
New data showed Actos prevented progression of atherosclerotic plaque volume in patients
Date:3/31/2008

Chicago, IL, March 31, 2008 New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS® (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline. These data stem from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) trial.

The PERISCOPE trial was presented today as a late breaker at the 57th Annual Scientific Session of the American College of Cardiology in Chicago. This trial adds to the body of cardiovascular data for ACTOS. ACTOS studies, conducted over the past 10 years in more than 16,000 patients, including short- and long-term trials, as well as prospective and observational studies, have shown no evidence that ACTOS is associated with an increased risk of heart attack, stroke, or death.

We are pleased with the results of the PERISCOPE, which further expands our cardiovascular data with ACTOS, said David P. Recker, M.D., senior vice president, Clinical Sciences and interim president at Takeda Global Research & Development. While not definitive, data from PERISCOPE combined with results from a previous study, looking at surrogate endpoints, have shown a consistent trend toward decreasing cardiovascular risk by reducing the atherosclerotic burden in people with type 2 diabetes.

PERISCOPE is the first clinical trial to examine the effects of an oral antidiabetic medication on the development of coronary atherosclerosis in patients with type 2 diabetes using IVUS technology. The trial conducted in 97 centers in the U.S., Canada and Latin America with 543 patients, used IVUS imaging of the coronary arteries. The analysis demonstrated a statistically significant difference in percent change in coronary artery atheroma volume in favor of ACTOS treatment compared to glimepiride t
'/>"/>

Contact: Amy Losak
amy.losak@ketchum.com
917-865-6688
Takeda Pharmaceuticals North America
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
2. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
3. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
4. New study of Concerta showed significant improvement of ADHD symptom management in adults
5. African Americans at Risk for Low Calcium Intake - New Survey Finds Those Experiencing Symptoms of Lactose Intolerance May be Sidelining Dairy in Their Diets
6. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
7. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
8. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
9. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
10. One-third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
11. One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ter to chill out. Places such as backyard pool, ho...s should be very for cautious and always follow th... avoid facing dangerous situations parents have ta...e pool fences and pool alarms. But in case of spas...
...ho have also been diagnosed as HIV-positive seemed... their health status to others//. The study, the ...ns who work with HIV-positive men who are often un...y, co-workers or others about being diagnosed with...
...rious medical courses offered by unaided medical i...on and research department// of the Punjab governm... other similar medical and paramedical courses. R...nd students have also been invited for a consultat...
...es become inflamed or infected affecting 37 millio...nal surgery//. But now Acclarent has come up with ...volves inflating a small balloon in the sinus cavi...ed as a major breakthrough that offers hope to man...
Other Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
(Date:8/19/2008)...RNewswire/ -- Addrenex Pharmaceuticals (, http://w...this month to,further its goal of identifying and ... over the next 18 months., The fast-paced timelin...pany,s recent successes in developing two new drug... disorder and CloniBID for hypertension,over the ...
(Date:8/19/2008)...wswire-FirstCall/ -- Vical Incorporated,(Nasdaq: ...th the Karolinska,Institutet (KI), a leading Europ...for Infectious Disease Control (SMI), a government... adjuvant with the Biojector(R),2000 needle-free i...,OTCBB: BJCT) for a multivalent preventive DNA va...
(Date:8/19/2008)...9 /- VION,PHARMACEUTICALS, ...ad,entered into an agreement with the Dutch-Belgia...(the "HOVON") to conduct a clinical trial of,larom...remission-induction,therapy in patients aged 18-65...mia (AML) and high-risk myelodysplasia (MDS)., Al...
(Date:8/18/2008)... /PRNewswire-USNewswire/ -- Due to an,exceptionall...es in,southeastern Pennsylvania, the Department of...will be stepping up efforts this week to combat th...kely to carry -- the virus., While only one human...is year (a 27-year-old Montgomery County woman), D...
Breaking Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Plan expedites alternatives to animal testing 11052 1Plan expedites alternatives to animal testing 11052 2Plan expedites alternatives to animal testing 11052 3Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 1Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 2Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 3Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 4Stacy DeFoe Earns Certified Association Executive Credential 11049 1Stacy DeFoe Earns Certified Association Executive Credential 11049 2Vestergaard Frandsen to Launch High Tech Filter to Provide Clean and Safe Drinking Water to People in Developing Nations 11047 1
...ed 41 to 50% of Patients and Was,Well-Tolerated ,P... News Network),-- Barrier Therapeutics, Inc. (NASD...and markets dermatology products, today,announced ...ozole,in lamellar ichthyosis, a rare genetic disor...h is characterized by a thick,scaling of the skin ...
... 14, 2007 /PRNewswire/ -- PARI Pharma will,present...ing drug,delivery system as well as lung depositio...haled liposomal Ciclosporin A formulation in,lung ...s Conference,(ECFC) in Belek, Turkey this week. , ...vanced,inhalation delivery platforms, PARI has cre...
Other Medicine Technology:Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 2Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 3Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 4Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 5PARI Pharma Presents Study Results of Sinus Delivery and Inhaled,Liposomal Ciclosporin A at European Cystic Fibrosis Conference 2
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: